Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828308 · ClinicalTrials.gov registry record · Phase 2
Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer
A Phase 2 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00828308 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 16 participants.
The verdict
NCT00828308, a Phase 2 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
Ixabepilone, 16 mg/m2 or 20mg/m2, weekly x 3, in 4 week cycles, x 4 cycles. Prostatectomy 2-8 weeks after completion(standard of care and not a part of study)
Interventions
- DRUG Ixabepilone
- PROCEDURE Prostatectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00828308
The ClinicalTrials.gov registry entry for NCT00828308 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ixabepilone is the first listed.
NCT00828308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00828308 about?
NCT00828308 is a clinical study titled "Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer". Ixabepilone, 16 mg/m2 or 20mg/m2, weekly x 3, in 4 week cycles, x 4 cycles. Prostatectomy 2-8 weeks after completion(standard of care and not a part of study)
What is the current status of trial NCT00828308?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2009-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00828308?
The interventions under investigation include: Ixabepilone (DRUG), Prostatectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00828308?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.